215 related articles for article (PubMed ID: 10926206)
1. Characterization of RNABP, an RNA binding protein that associates with RNase L.
Le Roy F; Laskowska A; Silhol M; Salehzada T; Bisbal C
J Interferon Cytokine Res; 2000 Jul; 20(7):635-44. PubMed ID: 10926206
[TBL] [Abstract][Full Text] [Related]
2. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes.
Khabar KS; Dhalla M; Siddiqui Y; Zhou A; Al-Ahdal MN; Der SD; Silverman RH; Williams BR
J Interferon Cytokine Res; 2000 Jul; 20(7):653-9. PubMed ID: 10926208
[TBL] [Abstract][Full Text] [Related]
3. RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells.
Martinand C; Salehzada T; Silhol M; Lebleu B; Bisbal C
Eur J Biochem; 1998 Jun; 254(2):248-55. PubMed ID: 9660177
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway.
Bisbal C; Martinand C; Silhol M; Lebleu B; Salehzada T
J Biol Chem; 1995 Jun; 270(22):13308-17. PubMed ID: 7539425
[TBL] [Abstract][Full Text] [Related]
5. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
Malathi K; Dong B; Gale M; Silverman RH
Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
[TBL] [Abstract][Full Text] [Related]
6. 2',5'-Oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits.
Salehzada T; Silhol M; Steff AM; Lebleu B; Bisbal C
J Biol Chem; 1993 Apr; 268(11):7733-40. PubMed ID: 8463302
[TBL] [Abstract][Full Text] [Related]
7. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection.
Li XL; Blackford JA; Hassel BA
J Virol; 1998 Apr; 72(4):2752-9. PubMed ID: 9525594
[TBL] [Abstract][Full Text] [Related]
8. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract][Full Text] [Related]
9. Studies on interferon-sensitive cells derived from the interferon-resistant NIH 3T3 clone 1 line.
Mittnacht S; Jacobsen H
Prog Clin Biol Res; 1985; 202():237-45. PubMed ID: 2421304
[TBL] [Abstract][Full Text] [Related]
10. Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.
Kumar R; Choubey D; Lengyel P; Sen GC
J Virol; 1988 Sep; 62(9):3175-81. PubMed ID: 2841470
[TBL] [Abstract][Full Text] [Related]
11. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L.
Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y
Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291
[TBL] [Abstract][Full Text] [Related]
12. RNase L plays a role in the antiviral response to West Nile virus.
Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
[TBL] [Abstract][Full Text] [Related]
13. The 2-5A system in viral infection and apoptosis.
Castelli J; Wood KA; Youle RJ
Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
[TBL] [Abstract][Full Text] [Related]
14. Localization of a molecular form of interferon-regulated RNase L in the cytoskeleton.
Tnani M; Aliau S; Bayard B
J Interferon Cytokine Res; 1998 Jun; 18(6):361-8. PubMed ID: 9660242
[TBL] [Abstract][Full Text] [Related]
15. 2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.
Frémont M; El Bakkouri K; Vaeyens F; Herst CV; De Meirleir K; Englebienne P
Exp Mol Pathol; 2005 Jun; 78(3):239-46. PubMed ID: 15924878
[TBL] [Abstract][Full Text] [Related]
16. Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta.
Rusch L; Zhou A; Silverman RH
J Interferon Cytokine Res; 2000 Dec; 20(12):1091-100. PubMed ID: 11152576
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of 2',5'-oligo(A)-dependent endoribonuclease by 2',5'-oligo(A) degradation products.
Williams GJ; De Benedetti A; Baglioni C
Virology; 1986 Jun; 151(2):233-42. PubMed ID: 2422811
[TBL] [Abstract][Full Text] [Related]
18. Effect of interferon on two human choriocarcinoma-derived cell lines.
Vandenbussche P; Kuwata T; Verhaegen-Lewalle M; Content J
Virology; 1983 Jul; 128(2):474-9. PubMed ID: 6310868
[TBL] [Abstract][Full Text] [Related]
19. RNase L triggers autophagy in response to viral infections.
Chakrabarti A; Ghosh PK; Banerjee S; Gaughan C; Silverman RH
J Virol; 2012 Oct; 86(20):11311-21. PubMed ID: 22875977
[TBL] [Abstract][Full Text] [Related]
20. 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.
Rice AP; Roberts WK; Kerr IM
J Virol; 1984 Apr; 50(1):220-8. PubMed ID: 6422053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
